Over 4,000 people downloaded Courage Against Cancer’s free guides last month. Now, one small $5 donation can help bring life-saving treatments closer to FDA approval — so one day, no child or family will be denied care because of cost.
Tag: cancer research
The future of cancer treatment lies in combination. Discover the compelling science suggesting how repurposed drugs like ivermectin and mebendazole could work synergistically with standard therapies to improve outcomes and overcome treatment resistance.
Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates
Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!
G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬
We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.
It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.
Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨
Preclinical trials serve as a critical stepping stone in the journey from laboratory discovery to human application, especially in the realm of non-conventional cancer therapies. This article examines the significance of preclinical trials in the therapeutic development of promising drugs like Ivermectin and Mebendazole. By highlighting their current research landscape, we emphasize the undeniable importance of this phase in paving the way for groundbreaking cancer treatments.
Repurposing existing drugs like ivermectin and mebendazole offers a groundbreaking path forward in the war against cancer. Learn how Courage Against Cancer’s preclinical work on ovarian cancer may help establish the safety, mechanisms, and efficacy of these overlooked therapies — and how you can help us bridge science and compassion in the fight for human healing.
In a landscape dominated by hype and headlines, our foundation is dedicated to a single, clear mission: moving the conversation about repurposed drugs like ivermectin and mebendazole from anecdote to evidence through rigorous, independent science.
Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.
Courage Against Cancer 